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Background:  Heart failure (HF) has been referred to as a global epidemic; yet, there are few data from lower/middle income countries.
methods:  INTER-CHF is a prospective HF registry from 15 countries in Africa, Asia, the Middle East and South America.
results:  5764 patients were recruited: 2650 from Asia, 1000 from the Middle East, 1291 from Africa and 823 from South America. Women 
were more likely than men to be in NYHA Class III/IV, atrial fibrillation, have preserved left ventricular function and moderate/severe 
valve disease on echo, but less likely to use alcohol/tobacco, or have had prior MI.(Table) Women were more often illiterate (35vs.15%), 
uneducated (56vs.35%), unemployed (87vs.66%) and have no health/medication insurance (55/47vs.47/40%;p<0.001). Women were 
less likely than men to be on a beta-blocker (59vs.69%), ACEi/ARB (70vs.77%), aldosterone inhibitor (46vs.52%;p<0.001), or to have 
had cardiac surgery (6vs.11%), stent/PCI (9vs.19%) or implantable cardiac device (4vs.9%;p<0.001 for all). The top HF etiologies for 
women and men, respectively, were ischemic (30vs.48%), hypertensive (23vs.16%), idiopathic-dilated (11vs.16%), and valvular-rheumatic 
(15vs.6%;p<0.001).
conclusion:  INTER-CHF, the first prospective HF registry in Africa, Asia, the Middle East and South America, reveals significant 
differences between women and men with HF. These factors could impact HF care and outcomes.
